Literature DB >> 14648814

Auditory neuropathy/dys-synchrony: diagnosis and management.

Charles I Berlin1, Linda Hood, Thierry Morlet, Kelly Rose, Shanda Brashears.   

Abstract

Auditory brainstem responses (ABRs) and otoacoustic emissions (OAEs) are objective measures of auditory function, but are not hearing tests. Normal OAEs reflect normal cochlear outer hair cell function, and an ABR indicates a synchronous neural response. It is quite possible for a patient to have normal OAEs but absent or grossly abnormal ABR and a behavioral audiogram that is inconsistent with either test. These patients, who may constitute as much as 10% of the diagnosed deaf population, have auditory neuropathy/dys-synchrony (AN/AD). To diagnose AN/AD accurately, ABRs are obtained in response to condensation and rarefaction clicks to distinguish cochlear microphonics (CM) from neural responses. Appropriate management is confounded by variation among patients and changes in auditory function in some patients over time. Recommendations for management include visual language exposure through methods such as American Sign Language (ASL), Cued Speech, or baby signs, and closely following patients. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 14648814     DOI: 10.1002/mrdd.10084

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  25 in total

Review 1.  Plasticity in the developing auditory cortex: evidence from children with sensorineural hearing loss and auditory neuropathy spectrum disorder.

Authors:  Garrett Cardon; Julia Campbell; Anu Sharma
Journal:  J Am Acad Audiol       Date:  2012-06       Impact factor: 1.664

2.  Response pattern based on the amplitude of ear canal recorded cochlear microphonic waveforms across acoustic frequencies in normal hearing subjects.

Authors:  Ming Zhang
Journal:  Trends Amplif       Date:  2012-06-13

3.  Using a combination of click- and tone burst-evoked auditory brain stem response measurements to estimate pure-tone thresholds.

Authors:  Michael P Gorga; Tiffany A Johnson; Jan R Kaminski; Kathryn L Beauchaine; Cassie A Garner; Stephen T Neely
Journal:  Ear Hear       Date:  2006-02       Impact factor: 3.570

Review 4.  [Diagnosis and therapy of auditory synaptopathy/neuropathy].

Authors:  T Moser; N Strenzke; A Meyer; A Lesinski-Schiedat; T Lenarz; D Beutner; A Foerst; R Lang-Roth; H von Wedel; M Walger; M Gross; A Keilmann; A Limberger; T Steffens; J Strutz
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

5.  Cortical maturation and behavioral outcomes in children with auditory neuropathy spectrum disorder.

Authors:  Anu Sharma; Garrett Cardon; Kathryn Henion; Peter Roland
Journal:  Int J Audiol       Date:  2011-02       Impact factor: 2.117

6.  Brain stem and inner ear abnormalities in children with auditory neuropathy spectrum disorder and cochlear nerve deficiency.

Authors:  B Y Huang; J P Roche; C A Buchman; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-01       Impact factor: 3.825

7.  Imaging characteristics of children with auditory neuropathy spectrum disorder.

Authors:  Joseph P Roche; Benjamin Y Huang; Mauricio Castillo; Marc K Bassim; Oliver F Adunka; Craig A Buchman
Journal:  Otol Neurotol       Date:  2010-07       Impact factor: 2.311

8.  Survival of adult spiral ganglion neurons requires erbB receptor signaling in the inner ear.

Authors:  Konstantina Stankovic; Carlos Rio; Anping Xia; Mitsuru Sugawara; Joe C Adams; M Charles Liberman; Gabriel Corfas
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

9.  N100 cortical potentials accompanying disrupted auditory nerve activity in auditory neuropathy (AN): effects of signal intensity and continuous noise.

Authors:  Henry J Michalewski; Arnold Starr; Fan-Gang Zeng; Andrew Dimitrijevic
Journal:  Clin Neurophysiol       Date:  2009-06-16       Impact factor: 3.708

10.  Evaluation of inner hair cell and nerve fiber loss as sufficient pathologies underlying auditory neuropathy.

Authors:  Mohamed M El-Badry; Sandra L McFadden
Journal:  Hear Res       Date:  2009-06-14       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.